Skip to main navigation Skip to search Skip to main content

Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany.

  • Winfried März* (First author)
  • , FW Dippel
  • , K Theobald
  • , K Gorcyca
  • , ŞR Iorga
  • , D Ansell
  • *Corresponding author for this work

Research output: Contribution to journalResearch article

77 Citations (Web of Science)
Original languageEnglish
JournalAtherosclerosis
DOIs
Publication statusPublished - 2018

Branches of science

  • 302 Clinical Medicine

Cite this